• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Morocco Pharmaceuticals and Healthcare Report Q1 2013 - Product Image

Morocco Pharmaceuticals and Healthcare Report Q1 2013

  • ID: 2373695
  • January 2013
  • Region: Morocco
  • 101 pages
  • Business Monitor International

FEATURED COMPANIES

  • Company Profiles
  • GlaxoSmithKline
  • Laprophan
  • Local Companies
  • Multinational Companies
  • Pfizer
  • MORE

BMI View:

Morocco's subsidised health insurance scheme, Régime d'Assistance Médicale
(RAMED), launched in March 2012, is experiencing early-stage difficulties with its target to increase healthcare accessibility to those on low incomes. This is to be expected, given the evidence of bribery and corruption, and the shortage of doctors in the sector. BMI believes the commitment to improve governance and implement controls in the sector will be fulfilled in the medium-to-long term. As such, we maintain that government healthcare spending will outpace private healthcare spending over the forecast 2011-2016 period.

Headline Expenditure Projections

- Pharmaceuticals: MAD10.10bn (US$1.25bn) in 2011 to MAD11.24bn (US$1.30bn) in 2012;
+11.3% in local currency terms and +4.5% in US dollar terms. Forecast broadly unchanged from Q412.

- Healthcare: MAD41.99bn (US$5.19bn) in 2011 to MAD47.09bn (US$5.46bn) in 2012; +12.2
%in local currency terms and +5.4% in US dollar terms. Forecast slightly higher from Q412, on account of slightly lower historical figures.

- Medical devices: MAD2.19bn (US$270mn) in 2011 to MAD2.47bn (US$287mn) in 2012;
+13.1% READ MORE >

FEATURED COMPANIES

  • Company Profiles
  • GlaxoSmithKline
  • Laprophan
  • Local Companies
  • Multinational Companies
  • Pfizer
  • MORE

Executive Summary 5

SWOT Analysis 7

Morocco Pharmaceuticals And Healthcare Industry SWOT 7

Morocco Political SWOT 8

Morocco Economic SWOT 8

Morocco Business Environment SWOT 9

Pharmaceutical Risk/Reward Ratings 10
Table: Middle East And Africa Pharmaceutical Risk/Reward Ratings, Q113 10

Rewards 11

Risks 12

Market Summary - Morocco 14

Regulatory Regime 15

Intellectual Property Regime 16

Pricing Regime 16

Reimbursement Regime 18
Table: National Insurance Fund Spending On Select Conditions, 2006-2009 20

Industry Developments 21

Epidemiology 21

Communicable Diseases 23

Non-Communicable Diseases 24

Healthcare Sector 26

Healthcare Financing 27

Healthcare Sector Developments 29

Healthcare Reform 30

Health Insurance 31

Recent Health Insurance Developments 33

Clinical Trials 35

Research & Development 36

Medical Devices Market 36

Industry Forecast Scenario 38

Pharmaceutical Market Forecasts 38
Table: Pharmaceutical Sales Indicators 2008-2016 39

Healthcare Market Forecast 41
Table: Healthcare Expenditure Indicators 2008-2016 43
Table: Healthcare Governmental Indicators 2008-2016 43
Table: Healthcare Private Indicators 2008-2016 44

Key Growth Factors - Macroeconomic Forecast 45
Table: Morocco - Economic Activity 53

Prescription Drug Market Forecast 54
Table: Leading Therapeutic Classes, 2010 55
Table: Private Pharmacy Sales Value And Volume By Principal Therapeutic Categories, 2010 55
Table: Prescription Drug Sales Indicators, 2008-2016 56

Patented Drug Market Forecast 57
Table: Patented Drug Market Indicators, 2008-2016 58

Generic Drug Market Forecast 59
Table: Generic Drug Sales Indicators, 2008-2016 61

OTC Medicine Market Forecast 62
Table: OTC Medicine Sales Indicators, 2008-2016 63

Pharmaceuticals Trade Forecast 64
Table: Exports And Imports Indicators, 2008-2016 65

Medical Device Market Forecast 66
Table: Medical Devices Sales Indicators, 2008-2016 67

Other Healthcare Data Forecasts 68

Key Risks To BMI's Forecasts 69

Competitive Landscape 70

Pharmaceutical Industry 70
Table: Members Of AMIP, 2011 70
Table: Members Of MIS, 2011 71

Domestic Pharmaceutical Sector 72

Foreign Pharmaceutical Companies 73

Pharmaceutical Wholesale 75

Pharmaceutical Retail 76

Company Profiles 77

Local Companies 77

Sothema 77

Laprophan 79

Promopharm 81

Multinational Companies 83

Sanofi 83

Pfizer 85

GlaxoSmithKline 87

Ranbaxy 89
Table: Morocco's Population By Age Group, 1990-2020 ('000) 92
Table: Morocco's Population By Age Group, 1990-2020 (% of total) 92
Table: Morocco's Key Population Ratios, 1990-2020 93
Table: Morocco's Rural And Urban Population, 1990-2020 93

Glossary 95

BMI Methodology 97

How We Generate Our Pharmaceutical Industry Forecasts 97

Pharmaceuticals Risk/Reward Ratings Methodology 98

Ratings Overview 98
Table: Pharmaceutical Business Environment Indicators 99

Weighting 100
Table: Weighting Of Components 100

Sources 100

Company Profiles
Local Companies
Sothema
Laprophan
Promopharm
Multinational Companies
Sanofi
Pfizer
GlaxoSmithKline
Ranbaxy

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos